CN1116046C - Injection for curing primary varix of lower limb - Google Patents

Injection for curing primary varix of lower limb Download PDF

Info

Publication number
CN1116046C
CN1116046C CN 00104410 CN00104410A CN1116046C CN 1116046 C CN1116046 C CN 1116046C CN 00104410 CN00104410 CN 00104410 CN 00104410 A CN00104410 A CN 00104410A CN 1116046 C CN1116046 C CN 1116046C
Authority
CN
China
Prior art keywords
injection
varix
lower limb
present
cirso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 00104410
Other languages
Chinese (zh)
Other versions
CN1328826A (en
Inventor
满亚洲
张宏丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 00104410 priority Critical patent/CN1116046C/en
Publication of CN1328826A publication Critical patent/CN1328826A/en
Application granted granted Critical
Publication of CN1116046C publication Critical patent/CN1116046C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an injection used for treating primary varicose vein of lower limbs, which is composed of the components with the proportion by weight: 15 portions of medical sodium chloride and 0.5 portion of lidocaine. The composition is reasonable and novel. The results of 500 examples of clinical tests prove that the present invention has the advantages of obvious and exact treatment effect, one time cure rate which is as high as 91.2%, no toxic or side effect, no complications, low expense, etc.

Description

The injection of treatment primary varicosis of lower extremities
The present invention relates to a kind of injection that primary varicosis of lower extremities is used for the treatment of.
Primary varicosis of lower extremities is a kind of commonly encountered diseases frequently-occurring disease, according to relevant bibliographical information, south Weir sickness rate is 53%, Spain, France and New Zealand respectively are 40%, and Canada and Israel respectively are 20%, and the U.S. has 2,400 ten thousand patients approximately, and its cause of disease mainly is owing to venous valvular incompetence or stands prudent for a long time, make the intravenous increased pressure, or cold water stimulating causes.When the patient stood, the vein of lower limb expansion formed vein group tortuous, that wriggle, makes the pars affecta skin protuberance, and the shank position is more serious than thigh position; Crouch or after lower limb raised, the vein of varicose just disappeared when the patient is flat.The ill initial stage, to suffer from limb and often expand and the mild pain sense with acid, the later stage, atrophoderma appearred in regular meeting, pigmentation, symptoms such as scleroma and stasis dermatitis, chronic ulcer appear in skin, subcutaneous tissue.
At present, be used for the treatment of oral medicine being arranged and suffering from limb intravenous injection medicine of above-mentioned disease.Sodium morrhuate is domestic a kind of injection drug commonly used, the bad grasp of this pharmaceutical quantities, and weak curative effect, side effect is big, and through clinical practice (30 example), none routine one-time cure is injected at most 7 times as a result, also not complete obiteration, injection volume is big.Serious to vascular stimulation, injection back pain increases the weight of, and lasts up to for 2 weeks, occurs with allergic symptom individually.One patient Ms Zhang is wherein arranged, 38 years old, left lower extremity constitutional great saphenous varicose vein, use the 5ml sodium morrhuate and do to suffer from the shot of limb cirso-, the shank serious swelling can not be walked with descending and be reached half surplus month as a result, and the swelling that just disappears was treated in swelling half surplus year through 8 months.
The objective of the invention is to solve problems of the prior art, and provide a kind of dosage little, no complication, the one-time cure rate height has no side effect, the injection of the primary varicosis of lower extremities treatment usefulness that relapse rate is low.
Technical scheme of the present invention is based on understanding and Therapeutic Principle to primary varicosis of lower extremities mechanism, and it is main being beneficial to suffer from limb cirso-sclerosis of blood vessels, is the auxilliary medicament composing prescription that carries out with local anesthesia.
A kind of injection for the treatment of primary varicosis of lower extremities is characterized in that being made of sodium chloride medical sodium chloride and lignocaine: lignocaine=15: 0.5 (weight).
The injection of treatment primary varicosis of lower extremities provided by the invention shows through clinical effectiveness, has one-time cure rate up to 91.2%, in 12 months relapse rate low, have no side effect, no complication occurs, the prescription novelty, evident in efficacy definite, advantage such as expense is low.
The application of the injection that treatment primary varicosis of lower extremities provided by the invention is used:
Make the patient stand the vein of its varicose is fully swelled, hitch huckle with tourniquet, allow the patient sit down then or flat crouching, thrust the hypomere of the cirso-of protuberance with scalp acupuncture, use immobilization with adhesive tape, lift the trouble limb, unclamp tourniquet, the blood in the emptying cirso-, be tourniquet in the cirso-epimere again, lift lower limb and become 45 degree to push away medicine, twine Elastic bandage to proximal part, twine upper end always to cirso-by far-end.Its dosage is decided by state of an illness weight, is generally 5~15ml.
As mentioned above with the injection of treatment primary varicosis of lower extremities of the present invention, inject the cirso-of emptying, use the Elastic bandage pressure dressing, make medicinal liquid stimulate blood vessel wall to form aseptic chemistry inflammation, the blood vessel wall adhesion, remained blood forms thrombosis, whole cirso-vascular fibrosis after the machineization, inaccessible become dead space, make the blood can't adverse current and disappear.As seen 30 days above-mentioned Elastic bandages of disassemble are suffered from the limb cirso-and are disappeared.The atrophoderma that the ill later stage occurs, pigmentation, symptoms such as skin, hypodermic scleroma and stasis dermatitis fade away.
The present invention is through the clinical observation of 500 routine systems, and select medical history, the state of an illness, year make, sex and 30 suitable examples of former Therapeutic Method (sodium morrhuate) are matched group, wherein male 210 examples, women 290 examples, 20~78 years old age, the course of disease 1~36 year.Cure the disease as stated above.
Consumption: 5~15ml/ time, be generally 5ml/ time, heavily trouble can suitably increase consumption.Its clinical test results such as table 1.
Table 1 injection injection cirso-of the present invention is cured situation
Case load Once cure (example) Secondary is cured (example) Cure (example) three times Cure (example) 4~7 times Recurrence (example) in 12 months Remarks
Test group 500 456 28 16 0 7
Matched group 30 0 11 14 5 20
Test statistics shows: with injection of the present invention the patient of 500 routine primary varicosis of lower extremities is done therapeutic test, obtain significant curative effect, once cure and account for 91.2%, the secondary healing accounts for 5.6%, three healing and accounts for 3.2%, cures to recur in back 12 months to account for 1.4%, having no side effect, do not have complication occurs, the prescription novelty, determined curative effect, expense is low.
Points for attention:
Injection provided by the invention is to suffering from serious hypertension, heart disease, glomerulonephritis, the nephrotic syndrome, deep vein thrombosis of lower extremity, the seriously infull person's forbidding of dark vein valve function.
Embodiment 1
Get medical sodium chloride (Sodiam Chlotide) 150g, lignocaine (Lidocaine) hydrochlorate 5g places beaker, add a small amount of water for injection, after fully stirring makes it to dissolve fully, use filtering with microporous membrane, add the injection water to 1000ml from filter membrane, stir, be sub-packed in the 10ml peace bottle, in 100 ℃ of sterilizations 30 minutes, cool off stand-by.

Claims (1)

1, a kind of injection for the treatment of primary varicosis of lower extremities is characterized in that being mixed with by 15: 0.5 weight ratios with medical sodium chloride, lignocaine, and its quality concentration expressed in percentage by volume sodium chloride is 15%, and lignocaine is 0.5%.
CN 00104410 2000-06-21 2000-06-21 Injection for curing primary varix of lower limb Expired - Fee Related CN1116046C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00104410 CN1116046C (en) 2000-06-21 2000-06-21 Injection for curing primary varix of lower limb

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00104410 CN1116046C (en) 2000-06-21 2000-06-21 Injection for curing primary varix of lower limb

Publications (2)

Publication Number Publication Date
CN1328826A CN1328826A (en) 2002-01-02
CN1116046C true CN1116046C (en) 2003-07-30

Family

ID=4577299

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00104410 Expired - Fee Related CN1116046C (en) 2000-06-21 2000-06-21 Injection for curing primary varix of lower limb

Country Status (1)

Country Link
CN (1) CN1116046C (en)

Also Published As

Publication number Publication date
CN1328826A (en) 2002-01-02

Similar Documents

Publication Publication Date Title
WO2023231388A1 (en) Medicament for treating prostatitis in males and use thereof
CN101278963B (en) Liquid medicament for curing bedsore
CN1813766A (en) Ointment for treating hemorrhoid and its preparing method
CN1116046C (en) Injection for curing primary varix of lower limb
Garg et al. Ayurvedic perspective of varicose veins
CN101366968A (en) Compound magnesium sulfate wet-dressing agent and preparation method thereof
CN103977113B (en) A kind of Chinese medicine for the treatment of diabetic foot
WO2001064229A1 (en) A medicine for treating obesity and the method of producing thereof
CN113209179A (en) External washing medicine for hemorrhoids and fistula and preparation method and application method thereof
CN108114090B (en) A Chinese medicinal composition for treating hemorrhoid, burn and scald
CN100584375C (en) Formula for treating scar
CN102552295B (en) Medicine for treating internal and external hemorrhoids and preparation method thereof
CN109675008B (en) Traditional Chinese medicine composition for preventing and treating postpartum urinary retention and preparation method and application thereof
CN102755353A (en) Injection for treating varicosity
CN1178654C (en) Chloromycetin kibe ointment
CN101559185A (en) External medicament for curing varicose vein of lower limbs
CN1666761A (en) Medicine for quickly and radically treating piles
SU1156683A1 (en) Method of treatment of optochiasmal arachnoiditis
JPS6229529A (en) Manufacture of medicine for disease
RU2329026C2 (en) Method of biliary dyskinesia treatment
CN118697761A (en) Application of polidocanol in preparing medicament for treating lymphadenitis
CN107281217A (en) It is a kind of to be used to treat combination medicament of hemorrhoid and preparation method thereof
CN1463699A (en) A composition for treating animal endometritis
CN101940600B (en) Product for treating hemorrhoid and production method thereof
CN112826908A (en) External traditional Chinese medicine for treating haemorrhoids and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee